All In Biotech

Drug Trial Radar · NCT05508789

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,500 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,500

Planned (sponsor's estimate)

Start

Oct 10, 2022

Primary completion

May 2028

Study completion Jul 2028

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Aug 19, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The study duration including screening and follow-up is up to 93 weeks.

Conditions

  • Alzheimer Disease
  • Dementia
  • Brain Diseases
  • Central Nervous System Diseases
  • Nervous System Diseases
  • Tauopathies
  • Neurodegenerative Diseases
  • Neurocognitive Disorders
  • Mental Disorders

Interventions

  • DonanemabDrug

    Administered IV

  • PlaceboDrug

    Administered IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline on the Integrated Alzheimer's Disease Rating Scale (iADRS)Time frame: Baseline, Week 76

Locations

141 sites in 8 countries. Site status is shown where the registry gives one.

  • Hospital Italiano de Buenos Aires

    ABB, Argentina

  • Clinica Privada Banfield

    Banfield, Argentina

  • Fundación para el Estudio y Tratamiento de Enfermedades Mentales (FETEM)

    Buenos Aires, Argentina

  • Stat Research S.A.

    Buenos Aires, Argentina

  • Centro de Investigaciones Metabólicas (CINME)

    Buenos Aires, Argentina

  • CIPREC

    Buenos Aires, Argentina

  • Mautalen Salud e Investigación

    Buenos Aires, Argentina

  • Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada

    Buenos Aires, Argentina

  • Centro Médico Arsema

    Buenos Aires, Argentina

  • Instituto Geriatrico Nuestra Señora de Las Nieves

    Buenos Aires, Argentina

  • Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI)

    Buenos Aires, Argentina

  • Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC)

    Buenos Aires, Argentina

  • IDIM - Instituto de Investigaciones Metabólicas

    Ciudad de Buenos Aires, Argentina

  • INSA Instituto de Neurociencia San Agustin

    La Plata, Argentina

  • Instituto De Investigaciones Clinicas Quilmes

    Quilmes, Argentina

  • INECO Neurociencias Oroño

    Rosario, Argentina

  • Emeritus Research

    Botany, Australia

  • Box Hill Hospital

    Box Hill, Australia

  • The Prince Charles Hospital

    Brisbane, Australia

  • NeuroCentrix

    Carlton, Australia

  • Central Coast Neurosciences Research

    Erina, Australia

  • Austin Health

    Ivanhoe, Australia

  • Southern Neurology

    Kogarah, Australia

  • HammondCare

    Malvern, Australia

  • The Alfred Hospital

    Melbourne, Australia

  • Alzheimer's Research Australia

    Nedlands, Australia

  • The Royal Melbourne Hospital

    Parkville, Australia

  • St Vincent's Hospital

    Sydney, Australia

  • KARA Institute for Neurological Diseases

    Sydney, Australia

  • Central Coast Neurosciences Research (Tumbi Umbi)

    Tumbi Vmbi, Australia

  • Neurodegenerative Disorders Research

    West Perth, Australia

  • The Queen Elizabeth Hospital

    Woodville, Australia

  • Beijing Hospital

    Beijing, China

  • Beijing ChaoYang Hospital

    Beijing, China

  • Beijing Friendship Hospital Affiliate of Capital University

    Beijing, China

  • Xuanwu Hospital Capital Medical University

    Beijing, China

  • Beijing Tiantan Hospital Affiliated to Capital Medical University

    Beijing, China

  • Beijing Anding Hospital - Affiliated Capital University of Medical Science

    Beijing, China

  • Beijing Peking Union Medical College Hospital

    Beijing, China

  • Chinese PLA General Hospital

    Beijing, China

Showing 40 of 141 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.